Alliance Pharma (GB:APH) has released an update.
Alliance Pharma PLC has announced a significant change in their share ownership structure, with Lombard Odier Asset Management (Europe) Limited now holding 5.04% of the voting rights, crossing a notable threshold on October 9, 2024. This change, which was officially notified to the issuer on October 10, 2024, reflects a total of 27,264,340 voting rights within the company.
For further insights into GB:APH stock, check out TipRanks’ Stock Analysis page.